Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
51
Total 13F shares, excl. options
20.7M
Shares change
-4.16M
Total reported value, excl. options
$71.6M
Value change
-$16.5M
Put/Call ratio
0.29
Number of buys
15
Number of sells
-38
Price
$3.46

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2023

68 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q1 2023.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20.7M shares of 264M outstanding shares and own 7.83% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (6.95M shares), VANGUARD GROUP INC (2.12M shares), BlackRock Inc. (1.95M shares), MORGAN STANLEY (1.12M shares), Artal Group S.A. (850K shares), MILLENNIUM MANAGEMENT LLC (691K shares), BANK OF AMERICA CORP /DE/ (681K shares), Temasek Holdings (Private) Ltd (567K shares), JPMORGAN CHASE & CO (560K shares), and UBS Group AG (531K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.